Why the anaesthetic team needs to know

Tirzepatide slows gastric emptying. Food left in the stomach raises the risk of regurgitation and aspiration, where stomach contents enter the lungs during general anaesthesia or deep sedation. The MHRA has highlighted this risk for GLP-1 and dual GIP/GLP-1 medicines.

The risk applies to more than major operations. Procedures under sedation may need a plan too. Mention Mounjaro at pre-assessment, and again if your dose changes, you develop symptoms or the procedure date moves.

No single stopping rule applies to everyone

Ignore old online advice to stop for one week before every procedure. The MHRA safety update notes UK product information sets no universal withholding schedule. The procedural team looks at you, your symptoms, the medicine and the procedure together.

The team may change your preparation, fasting advice, anaesthetic technique or timing. Follow the instructions for your own procedure. If two services give you different directions, ask them which to follow. Routine advice from a private prescribing clinic does not override the anaesthetist's plan.

What to tell the pre-assessment team

Give the generic name (tirzepatide), the brand (Mounjaro), your weekly dose, the date of your last injection and whether you are still increasing the dose. Report nausea, vomiting, bloating, reflux, abdominal discomfort or unusual fullness. Mention every symptom, even if you worry the procedure will be delayed.

Say whether you take Mounjaro for diabetes, weight management or both, and list insulin and any other diabetes medicines. Pausing or changing treatment affects blood glucose, so the plan has to cover aspiration risk and diabetes care together.

Emergency operations

If you need urgent surgery, tell the emergency and anaesthetic teams when you last injected and when you last ate or drank. Never delay emergency care because you injected recently. With those details, the clinical team plans around the risk.

A medicine alert on your phone or an up-to-date medicines list helps if you are too unwell to explain. Ask for privately prescribed medicines to go on your NHS record where possible, so staff are less likely to miss them in an urgent admission.

Restarting after the procedure

Ask for clear advice on when to restart, especially after a long gap, ongoing nausea, poor eating and drinking, or complications. The answer depends on your recovery and the reason you started treatment. Do not go straight back to your previous high strength because an old label shows it.

Find out who answers your questions after the operation: the surgical team, the diabetes team or the prescribing service. The plan should cover your other medicines and glucose monitoring where relevant. A good plan covers the time before and after the procedure, so you are not left sorting out conflicting internet advice while you recover. If the procedure is cancelled or postponed, check whether your medicine plan needs updating too.

Sources

Your own medicine leaflet and prescriber come first. A source from another country does not mean the same rule applies in the UK.

  1. Mounjaro UK Summary of Product Characteristics, updated September 2026 medicines.org.uk
  2. Mounjaro UK patient information leaflet medicines.org.uk
  3. MHRA: pulmonary aspiration during general anaesthesia or deep sedation gov.uk
  4. NHS Specialist Pharmacy Service: GLP-1 considerations and interactions sps.nhs.uk

Spotted something out of date? Report a mistake.